Prevention of brain infarction by postischemic administration of histidine in rats.

Focal cerebral ischemia for 2 h by occlusion of the right middle cerebral artery provoked severe brain infarction in the rat brain after 24 h. Intraperitoneal administration of histidine, a precursor of histamine, immediately and 6 h after reperfusion, alleviated brain infarction. The infarct size in the histidine (200 mg/kg, 500 mg/kg, and 1000 mg/kg, each time) groups was 71%, 39%, and 7% of that in the control group, respectively. Although intracerebroventricular administration of mepyramine (3 nmol), an H1 antagonist, did not affect the morphologic outcome in histidine-treated rats, ranitidine (30 nmol), an H2 antagonist, completely abolished the alleviation caused by histidine. These findings indicate that postischemic administration of histidine prevents development of brain infarction by stimulating central histamine H2 receptors.
AuthorsNaoto Adachi, Keyue Liu, Tatsuru Arai
JournalBrain research (Brain Res) Vol. 1039 Issue 1-2 Pg. 220-3 (Mar 28 2005) ISSN: 0006-8993 [Print] Netherlands
PMID15781067 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Histamine H1 Antagonists
  • Histamine H2 Antagonists
  • Neuroprotective Agents
  • Histidine
  • Ranitidine
  • Pyrilamine
  • Animals
  • Brain Ischemia (complications, drug therapy)
  • Disease Models, Animal
  • Functional Laterality
  • Histamine H1 Antagonists (administration & dosage)
  • Histamine H2 Antagonists (administration & dosage)
  • Histidine (administration & dosage)
  • Infarction, Middle Cerebral Artery (drug therapy, etiology, pathology, prevention & control)
  • Injections, Intraperitoneal
  • Injections, Intraventricular
  • Male
  • Motor Activity (drug effects)
  • Neurons (drug effects, pathology)
  • Neuroprotective Agents (administration & dosage)
  • Pyrilamine (administration & dosage)
  • Ranitidine (administration & dosage)
  • Rats
  • Rats, Wistar
  • Statistics, Nonparametric

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: